Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Current Issues and Future Opportunities Will Be Discussed at the Council for Entrepreneurial Development’s MedTech 2008 on March 6, 2008

Abstract:
Advanced medical technology is the frontier of healthcare and quality of life issues. Current issues and future opportunities will be discussed by national and local industry leaders at the Council for Entrepreneurial Development's MedTech 2008 on March 6, 2008, at the Fuqua School of Business on the Duke University campus in Durham, N.C. The event, the only one of its kind in the Southeast and Mid-Atlantic regions, features panel discussions, expert commentaries and networking opportunities for medical technology companies, investors and service providers. Interview and photo opportunities are available. Please contact Cassandra Cranston at or 919-226-0460 to make arrangements.

Current Issues and Future Opportunities Will Be Discussed at the Council for Entrepreneurial Development’s MedTech 2008 on March 6, 2008

DURHAM, NC | Posted on February 28th, 2008

8 a.m. - 9 a.m. Breakfast & Registration (interviews and photo shoots may be scheduled during this period)

9 a.m. - 10:30 a.m. Opening Remarks and Featured Speaker: Ronald W. Dollens, retired president and CEO, Guidant Corporation, manufacturer of cardiovascular devices. During his tenure, the company became one of the largest medical technology companies in the world, introducing several breakthrough technologies including the internal defibrillator.

10:30 a.m. - 10:45 a.m. Break (interviews and photo shoots may be scheduled during this period)

10:45 a.m. - 12 noon, Alternatives to Growing a Medical Device Company

A panel exploring the alternative paths for financing growth.

Panelists:

* Moderator: Kevin Connors, general partner, Spray Venture Partners, a Newton, Mass., venture capital firm
* David Milne, managing partner, SV Life Sciences, a venture capital adviser and manager, with offices in Boston, San Francisco and London
* Richard West, CEO, Advanced Liquid Logic, Inc., an RTP-based developer of lab-on-a-chip technology

12 noon - 1:30 p.m. Lunch & Featured Speaker: Richard S. Stack, M.D., president, Synecor, LLC, a business generator and financial incubator of new medical device companies, based in RTP, Santa Rosa and Silicon Valley, Calif. (interviews and photo shoots may be scheduled during the lunch portion)

1:30 p.m. - 1:45 p.m. Break (interviews and photo shoots may be scheduled during this period)

1:45 p.m. - 3 p.m. Convergent Technologies Changing the Face of Medicine

A discussion of this mega-trend of integrating drugs, devices, nanotechnology, software and electrical engineering into smart devices.

Panelists:

* Moderator: Fred McCoy, vice chairman, Synecor LLC, an RTP-based business generator and financial incubator of new medical device companies with offices in Santa Rosa and Silicon Valley, Calif.
* Geoffrey Erickson, Ph.D., president and CEO of Humacyte, Inc., an Orlando-based company that grows medical devices from human cells to integrate easily within the body and act as replacement tissues.
* John J. Smith, M.D., J.D., partner, Hogan & Hartson LLP, a Washington, D.C.-based law firm with 22 offices worldwide and a strong regulatory affairs practice.

3 p.m. - 4 p.m. Global Clinical Trials

A panel featuring practical, experience-based stories of successful First-In-Man and global clinical trials.

Panelists:

* Moderator: H. Richard Davis, CTO, Tryton Medical, Inc., the Newton, Mass. maker of stents which has done extensive FIM studies in Germany and the Netherlands.
* James F. Buck, vice president of marketing and business development, InnerPulse, Inc., the RTP-based developer of an implantable cardioverter defibrillator designed to treat sudden cardiac arrest.
* John Funkhouser, president and CEO, nContact Surgical, Inc., the Morrisville-based medical device company that developed a cardiac coagulation device for the treatment of arrhythmias of the heart.

4 p.m. - 5 p.m. Closing Reception (interviews and photo shoots may be scheduled during this period)

Upcoming CED Events

The media is invited to attend the following CED events. Please contact Cassandra Cranston at or 919-226-0460 for press credentials.

April 16-18: Venture Conference: An annual venture conference which showcases the Southeast and Mid-Atlantic regions' best and most diverse investment opportunities and offers expansive entrepreneurial and investor networking. Held at the Washington Duke Inn & Golf Club in Durham, N.C. For more information, visit www.cednc.org/conferences/venture/2008/.

May 19-20: Biotech Conference: An annual industry conference where entrepreneurs, investors, and scientists learn about life science industry trends and discover new business and partnership opportunities. Held at the Benton Convention Center in Winston-Salem, N.C. For more information, visit www.cednc.org/conferences/biotech/2008/.

####

About Council for Entrepreneurial Development
CED identifies, enables and promotes high growth, high impact entrepreneurial companies and accelerates the entrepreneurial culture of the Research Triangle and North Carolina.

For more information, please click here

Contacts:


The Council for Entrepreneurial Development
Cassandra Cranston, 919-226-0460

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Events/Classes

A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024

Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

June Conference in Grenoble, France, to Explore Pathways to 6G Applications, Including ‘Internet of Senses’, Sustainability, Extended Reality & Digital Twin of Physical World: Organized by CEA-Leti, the Joint EuCNC and 6G Summit Sees Telecom Sector as an ‘Enabler for a Sustainabl June 1st, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project